Pre-exposure prophylaxis for HIV prevention in Europe – the status quo
A new ECDC Evidence Brief summarises many of the key issues across Europe regarding implementation of PrEP and provides some options for action. It draws on country data reported to ECDC for Dublin Declaration monitoring in 2016.
Pre-exposure prophylaxis to prevent HIV among MSM in Europe
The results of two clinical studies, PROUD and IPERGAY, suggests that the use of pre-exposure prophylaxis (PrEP) for men who have sex with men (MSM) is an effective HIV prevention tool for Europe.
Pre-exposure prophylaxis for HIV in Europe
The use of pre-exposure prophylaxis (PrEP) as an HIV prevention strategy, particularly among men who have sex with men (MSM) as well as other population groups at higher risk of HIV infection, has been receiving more and more attention during 2014. Preliminary results of clinical trials and research studies suggest that it could be an effective HIV prevention tool for Europe.